Private equity firm Exponent has halted the auction of UK accounting group Xeinadin after potential buyers refused to meet its £1bn valuation, signaling potential headwinds for deal-making in the professional services sector.
Foundation Investment Partners, through its platform Sustainable Packaging, has acquired Paper Converters, a Walterboro-based manufacturer of spiral-wound paper tubes and boards, marking a strategic consolidation in the eco-friendly packaging sector.
Essar Oil and Gas Exploration & Production (EOGEPL) is injecting $100 million into its flagship Raniganj East CBM block in West Bengal, aiming to scale up domestic natural gas production and explore shale potential in a bid to reduce India's import reliance.
IPSASB unveils the world's first dedicated climate reporting standard for governments and public bodies, mandating disclosures from 2028 to illuminate financial risks and opportunities.
The fast-growing sunscreen brand Supergoop has named former Peloton marketing chief Lauren Weinberg as its new CMO, tasking her with expanding the brand's cultural footprint and driving growth across digital and product innovation.
A hefty cash reserve is typically a corporate strength, but for some companies, it signals stagnation rather than security. We examine three firms—Box, C3.ai, and Novavax—where significant net cash positions fail to offset concerns over growth prospects and valuation.
As e-commerce reshapes retail, some traditional consumer stocks struggle to keep pace. We examine three companies where valuation concerns and shifting market dynamics signal potential risk for investors.
As economic uncertainty weighs on consumer spending, discretionary stocks have lagged the broader market. We examine three companies—TEGNA, Sabre, and Compass—whose business models and valuations raise significant questions for investors in the current climate.
While rapid growth can inflate valuations, its sustainability separates market leaders from laggards. We analyze one company extending its competitive moat and two others where investors should tread carefully.
While large-cap stocks dominate markets with their scale, some industry titans are struggling to find new avenues for expansion. We examine three household names where valuation concerns and growth constraints signal potential underperformance.
Auna S.A. (NYSE:AUNA) saw its market value shed $55 million last week, with its largest shareholder group—private equity firms—absorbing the heaviest losses. We analyze the ownership structure and what it means for the Latin American healthcare provider's future.
The European CE Mark under the stringent MDR has been granted for Cynosure Lutronic's innovative fractional resurfacing system, designed to improve safety and patient comfort through advanced cooling and precision technology.
While investors chase AI and big tech, a niche biotech firm focused on rare genetic obesity disorders has quietly delivered staggering returns, with Wall Street seeing further 40% upside. Rhythm Pharmaceuticals' targeted approach and upcoming catalysts have analysts bullish, despite its relative anonymity.
A significant 32% stake in Mission Produce, Inc. (NASDAQ:AVO) is held by institutional investors, granting them considerable influence over the future of the world's leading avocado supplier. This concentrated ownership signals strong Wall Street confidence but also introduces volatility risks.
Investor appetite for hedge funds hits a record high, with quantitative and discretionary macro strategies leading demand. New data reveals these approaches captured over 70% of industry inflows last year, as allocators seek diversification and uncorrelated returns.
Goldman Sachs strategist Ben Snider highlights that over half of S&P 500 companies providing 2026 EPS forecasts are guiding above analyst expectations, a signal of underlying corporate confidence that contrasts with a less stellar Q4 earnings beat rate.
The world's largest cryptocurrency exchange has initiated the conversion of its user protection fund to Bitcoin, starting with a $100 million on-chain transfer. The move signals a strategic shift towards native crypto assets for safeguarding client funds.
BeOne Medicines extends its collaboration with quantitative systems pharmacology firm InSysBio, aiming to optimize clinical trial dosing and mitigate cytokine release syndrome risks across its broad portfolio of 15 novel oncology assets.
Eastern Bankshares (EBC) concludes a transformative year, reporting full-year 2025 results, affirming its dividend, and completing a share repurchase. The moves have propelled its stock, raising questions about its valuation amidst a shifting banking landscape.
BitMine Immersion Technologies (NYSEAM:BMNR) is navigating a turbulent period marked by over $6 billion in unrealized losses from its concentrated Ethereum holdings and the abrupt departure of its president. The company's aggressive crypto treasury strategy and governance decisions are now under the microscope.
